180 related articles for article (PubMed ID: 32370741)
21. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
[TBL] [Abstract][Full Text] [Related]
23. Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma.
Magnan H; Goodbody CM; Riedel E; Pratilas CA; Wexler LH; Chou AJ
Pediatr Blood Cancer; 2015 Apr; 62(4):594-7. PubMed ID: 25630954
[TBL] [Abstract][Full Text] [Related]
24. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
Wagner MJ; Gopalakrishnan V; Ravi V; Livingston JA; Conley AP; Araujo D; Somaiah N; Zarzour MA; Ratan R; Wang WL; Patel SR; Lazar A; Ludwig JA; Benjamin RS
Oncologist; 2017 Oct; 22(10):1271-1277. PubMed ID: 28710342
[TBL] [Abstract][Full Text] [Related]
25. Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis.
Black CM; Keeping S; Mojebi A; Ramakrishnan K; Chirovsky D; Upadhyay N; Maciel D; Ayers D
Front Oncol; 2022; 12():868490. PubMed ID: 35574411
[TBL] [Abstract][Full Text] [Related]
26. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
[TBL] [Abstract][Full Text] [Related]
27. Ewing sarcoma of the hand or foot.
Froeb D; Ranft A; Boelling T; Paulussen M; Klco-Brosius S; Jürgens H; Dirksen U
Klin Padiatr; 2012 Oct; 224(6):348-52. PubMed ID: 23143762
[TBL] [Abstract][Full Text] [Related]
28. Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer.
Korn EL; Sachs MC; McShane LM
Ann Oncol; 2016 Jan; 27(1):10-5. PubMed ID: 26489443
[TBL] [Abstract][Full Text] [Related]
29. Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis.
Ostoros G; Hettle R; Georgoulia N; Berktas M; Chander P; Diaz Perez I; Couto AM; Eichinger C; Field P; Morten P
Expert Rev Anticancer Ther; 2023; 23(12):1305-1313. PubMed ID: 37850939
[TBL] [Abstract][Full Text] [Related]
30. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
[TBL] [Abstract][Full Text] [Related]
31. Management and Outcome of Ewing Sarcoma of the Head and Neck.
Grevener K; Haveman LM; Ranft A; van den Berg H; Jung S; Ladenstein R; Klco-Brosius S; Juergens H; Merks JH; Dirksen U
Pediatr Blood Cancer; 2016 Apr; 63(4):604-10. PubMed ID: 26702872
[TBL] [Abstract][Full Text] [Related]
32. Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review.
Zhu J; Yang Y; Tao J; Wang SL; Chen B; Dai JR; Hu C; Qi SN; Li YX
Leukemia; 2020 Oct; 34(10):2576-2591. PubMed ID: 32651542
[TBL] [Abstract][Full Text] [Related]
33. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.
Paulussen M; Ahrens S; Burdach S; Craft A; Dockhorn-Dworniczak B; Dunst J; Fröhlich B; Winkelmann W; Zoubek A; Jürgens H
Ann Oncol; 1998 Mar; 9(3):275-81. PubMed ID: 9602261
[TBL] [Abstract][Full Text] [Related]
34. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
Norsworthy KJ; Gao X; Ko CW; Pulte ED; Zhou J; Gong Y; Shen YL; Vallejo J; Gwise TE; Sridhara R; Deisseroth AB; Farrell AT; de Claro RA; Blumenthal GM; Pazdur R
J Clin Oncol; 2022 Mar; 40(8):847-854. PubMed ID: 34890212
[TBL] [Abstract][Full Text] [Related]
35. Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial.
Frank JA; Ranft A; Paulussen M; Juergens H; Kruseova J; Bauer S; Niggli F; Reichardt P; Dirksen U
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436593
[TBL] [Abstract][Full Text] [Related]
36. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
[TBL] [Abstract][Full Text] [Related]
37. Systematic review of phase-I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research.
Felix A; Berlanga P; Toulmonde M; Landman-Parker J; Dumont S; Vassal G; Le Deley MC; Gaspar N
Cancer Med; 2021 Mar; 10(5):1589-1604. PubMed ID: 33452711
[TBL] [Abstract][Full Text] [Related]
38. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
39. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
[TBL] [Abstract][Full Text] [Related]
40. Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
Mascarenhas L; Felgenhauer JL; Bond MC; Villaluna D; Femino JD; Laack NN; Ranganathan S; Meyer J; Womer RB; Gorlick R; Krailo MD; Marina N
Pediatr Blood Cancer; 2016 Mar; 63(3):493-8. PubMed ID: 26579879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
